Axsome Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell AXSM and other ETFs, options, and stocks.About AXSM
Axsome Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which engages in the development of novel therapies for the management of central nervous system disorders. Its portfolio consists of Products Overview and Pipeline Overview.
CEOHerriott Tabuteau
CEOHerriott Tabuteau
Employees545
Employees545
HeadquartersNew York, New York
HeadquartersNew York, New York
Founded2012
Founded2012
Employees545
Employees545
AXSM Key Statistics
Market cap4.83B
Market cap4.83B
Price-Earnings ratio-14.84
Price-Earnings ratio-14.84
Dividend yield—
Dividend yield—
Average volume655.73K
Average volume655.73K
High today$100.48
High today$100.48
Low today$96.50
Low today$96.50
Open price$97.77
Open price$97.77
Volume481.65K
Volume481.65K
52 Week high$105.00
52 Week high$105.00
52 Week low$61.14
52 Week low$61.14
AXSM News
TipRanks 1d
Axsome Therapeutics announces AXS-12 achieves primary endpoint in ENCOREAxsome Therapeutics (AXSM) announced that AXS-12 achieved the primary endpoint in the ENCORE Phase 3 trial, demonstrating a statistically significant improvemen...
Simply Wall St 2d
Does Axsome Therapeutics Have A Healthy Balance Sheet?Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously said that 'Volatility is far from synonym...
Analyst ratings
100%
of 17 ratingsBuy
100%
Hold
0%
Sell
0%